Literature DB >> 6603224

Increased frequency of HLA-DR3 and DR4 in polymyalgia rheumatica-giant cell arteritis.

M B Lowenstein, P H Bridgeford, F B Vasey, B F Germain, L R Espinoza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603224     DOI: 10.1002/art.1780260717

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  6 in total

1.  HLA antigens in polymyalgia rheumatica in northern Sweden.

Authors:  A Uddhammar; B N Sojka; S Rantapää-Dahlqvist
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

Review 2.  Giant cell arteritis with ocular complications discovered simultaneously in two sisters.

Authors:  F Gros; J F Maillefert; A Behin; F Guignier; C Piroth; C Creuzot-Garcher; C Tavernier
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Giant cell vasculitis is a T cell-dependent disease.

Authors:  A Brack; A Geisler; V M Martinez-Taboada; B R Younge; J J Goronzy; C M Weyand
Journal:  Mol Med       Date:  1997-08       Impact factor: 6.354

4.  Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.

Authors:  A D Wagner; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica.

Authors:  T Ellingsen; P Elling; A Olson; H Elling; U Baandrup; K Matsushima; B Deleuran; K Stengaard-Pedersen
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

6.  The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.

Authors:  C M Weyand; K C Hicok; G G Hunder; J J Goronzy
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.